Correction from source: arcstone securities and investments corp. serves as exclusive financial advisor to mangoceuticals inc. (mgrx) on its transformative acquisition of ip assets of smokeless technology corp. marking its entry into the high growth oral stimulant pouch sector

Transaction marks arcstone's continued cross-border m&a franchise involving a nasdaq-listed company, underscoring the strength of its global platform and financial acumen in the news release, "arcstone securities and investments corp. serves as exclusive financial advisor to mangoceuticals inc." issued on 25-apr-2025 by arcstone over newsfile, the company has advised that the main heading should not have included "acquisition of smokeless technology corp." the complete, corrected release follows: transaction adds executive bench strength, ip and launches new business vertical for mangoceuticals in lucrative oral stimulant pouch segment on the heels of the significant success of turning point brands and philip morris international new york, new york and dallas, texas--(newsfile corp. - april 26, 2025) - arcstone securities and investments corp. ("arcstone"), a cross-border financial services firm, is pleased to announce its role as exclusive financial advisor to mangoceuticals inc. (nasdaq: mgrx) ("mangoceuticals") in its acquisition of ip, assets and technology from smokeless technology corp. ("smokeless tech"), a canadian-based innovator and disruptor in stimulant-based pouches and functional wellness delivery systems. this transaction marks arcstone's strategic m&a advisory expertise advising a nasdaq-listed acquirer and a privately held international company, underscoring the strength of its cross-border platform and domain expertise in health and wellness categories.
MGRX Ratings Summary
MGRX Quant Ranking